Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Susanne Schwalen"'
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 66:184-198
Zusammenfassung Hintergrund und Ziel Menschen mit geistiger Behinderung (MmgB) weisen eine erhöhte Morbidität auf. Ihr Zugang zur Gesundheitsversorgung könnte ein Einflussfaktor sein. In Deutschland existieren hierzu nur wenige Daten. Die vorliege
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a76ebc32862fb83e9d7af6c8c4072f1a
https://doi.org/10.1007/s00103-023-03655-x
https://doi.org/10.1007/s00103-023-03655-x
Publikováno v:
Das Gesundheitswesen. 84:457-465
Zusammenfassung Ziel der Studie Menschen mit geistiger Behinderung weisen eine geringere Lebenserwartung und häufigere Komorbidität als die Allgemeinbevölkerung sowie ungedeckte Gesundheitsbedarfe auf. Als ein Grund wird eine unzureichende medizin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14b24e88c8848ed6b0e36d6c05857cc1
https://doi.org/10.1055/a-1330-8081
https://doi.org/10.1055/a-1330-8081
Publikováno v:
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 84(5)
People with intellectual disabilities have a lower life expectancy and more frequent comorbidities than the general population and have unmet health needs. Insufficient medical care is suspected to be one reason, for which little data is available in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::899310e852cc404eaa6789a16f30fb4b
https://pubmed.ncbi.nlm.nih.gov/33890264
https://pubmed.ncbi.nlm.nih.gov/33890264
Autor:
Barbara Schäuble, Hans-Christoph Diener, Uwe Reuter, Joop Pfeil, Susanne Schwalen, Jean Schoenen, Joop van Oene
Publikováno v:
Cephalalgia. 30:1290-1295
Introduction: Demographic and clinical variables were examined in a post hoc analysis of the PROlonged Migraine Prevention with Topiramate (PROMPT) study to determine potential contribution to relapse. Methods: After a six-month open-label (OL) topir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586c02573c30e32961dc3aa2cd55d404
https://doi.org/10.1177/0333102409359709
https://doi.org/10.1177/0333102409359709
Autor:
Susanne Schwalen, Bart Van Baelen, Brian Everitt, Shane Kavanagh, Jean-François Dartigues, Tuula Pirttilä, Howard Feldman
Publikováno v:
International Journal of Geriatric Psychiatry. 24:479-488
Objective This study evaluated patient and treatment (galantamine and other acetylcholinesterase inhibitors (AChEIs)) factors associated with the time until nursing home placement (NHP) in patients with Alzheimer's disease (AD) with and without cereb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8692d8ef2a7ff36d7202b1e2a4d066c
https://doi.org/10.1002/gps.2141
https://doi.org/10.1002/gps.2141
Publikováno v:
Drugs & Aging. 26:231-239
Background: Galantamine (hydrobromide), a reversible acetylcholinesterase inhibitor and allosteric nicotinic receptor modulator, slows cognitive and functional decline in mild to moderate dementia of the Alzheimer’s type. Although several drugs are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684a38a20f30238de441eee4ca445e92
https://doi.org/10.2165/00002512-200926030-00004
https://doi.org/10.2165/00002512-200926030-00004
Publikováno v:
Clinical Therapeutics. 30:1180-1195
The efficacy of topiramate (TPM) as an adjunctive treatment for epilepsy has been established in placebo-controlled clinical trials. Clinical trials of antiepileptic monotherapy usually evaluate low and high doses of study drug or compare study drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d9ff5de0499ac17b14e5190c0cb4c6
https://doi.org/10.1016/s0149-2918(08)80045-8
https://doi.org/10.1016/s0149-2918(08)80045-8
Publikováno v:
Cephalalgia. 27:814-823
The aim of this study was to evaluate the efficacy and tolerability of topiramate for the prevention of chronic migraine in a randomized, double-blind, placebo-controlled trial. Chronic migraine is a common form of disabling headache presenting in he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b0182dea6ac9e7adae76928468c824
https://doi.org/10.1111/j.1468-2982.2007.01326.x
https://doi.org/10.1111/j.1468-2982.2007.01326.x
Publikováno v:
Sleep Medicine Clinics. 1:499-511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c609cac6f978718df7ed7fe0d5b2bc6
https://doi.org/10.1016/j.jsmc.2006.10.006
https://doi.org/10.1016/j.jsmc.2006.10.006
Autor:
Andreas Schreiner, Renzo Guerrini, Jože Grošelj, J. van Oene, Susanne Schwalen, Marjolein Lahaye
Publikováno v:
Acta Neurologica Scandinavica. 112:144-150
Objectives – To evaluate the effect of topiramate in elderly patients with onset of epilepsy after the age of 60, treatment-naive or non-responding to an initial antiepileptic drug. Methods – Analysis of patients with epilepsy diagnosed in the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e63856a065d06f64d64194e0391315
https://doi.org/10.1111/j.1600-0404.2005.00469.x
https://doi.org/10.1111/j.1600-0404.2005.00469.x